Metformin plus pioglitazone
KY20220314-02
Phase 3 small_molecule active
Quick answer
Metformin plus pioglitazone for Type 2 Diabetes is a Phase 3 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Type 2 Diabetes
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active